# Midwest Transplant Network – FDA Inspection, Feb 19, 2019

Source: https://www.keypedia.com/records/fda_inspections/midwest-transplant-network/2ab91f10-68b2-4c3f-bc01-b5c41485d138
Source feed: FDA_Inspections

> FDA inspection 1079774 of Midwest Transplant Network, February 19, 2019. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 1271. Form 483 issued. 11 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1079774
- Company Name: Midwest Transplant Network
- Inspection Date: 2019-02-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1272362 - 2025-04-25
- FDA Inspection 1067227 - 2018-09-13
- FDA Inspection 983887 - 2016-08-25
- FDA Inspection 883481 - 2014-06-02
- FDA Inspection 883467 - 2014-06-02

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/nimmy-mathews/9eac44d1-5e4c-493a-89c5-c7414a5a4037)
- [Issuing Officer](https://www.keypedia.com/people/william-f-lagud/c90c4bd6-bb56-4a60-a5f8-cbc648bb8dbe)

Company: https://www.keypedia.com/companies/midwest-transplant-network/78ec3255-91ac-4107-a969-60d1c7015db6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
